Patents by Inventor Juwon SHIM

Juwon SHIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS
    Publication number: 20230348584
    Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to promote a blood vessel normalization and treat a disease (e.g., cancer) in a subject in need thereof, e.g., by promoting a blood vessel normalization.
    Type: Application
    Filed: January 23, 2023
    Publication date: November 2, 2023
    Applicant: Neuracle Science Co., Ltd.
    Inventors: Bongcheol KIM, Eun Bee CHO, Dong Sik KIM, Jae-Keun LEE, Soon-gu KWON, Jae Young SEONG, Juwon SHIM, Tae Woo KIM, Shin-hyuk KANG
  • Use of anti-FAM19A5 antibodies for treating cancers
    Patent number: 11560425
    Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to promote a blood vessel normalization and treat a disease (e.g., cancer) in a subject in need thereof, e.g., by promoting a blood vessel normalization.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: January 24, 2023
    Assignee: Neuracle Science Co., Ltd.
    Inventors: Bongcheol Kim, Eun Bee Cho, Dong Sik Kim, Jae-Keun Lee, Soon-gu Kwon, Jae Young Seong, Juwon Shim, Tae Woo Kim, Shin-hyuk Kang
  • USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING ATHEROSCLEROSIS
    Publication number: 20220064277
    Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat an atherosclerosis in a subject in need thereof.
    Type: Application
    Filed: December 26, 2019
    Publication date: March 3, 2022
    Applicant: NEURACLE SCIENCE CO., LTD.
    Inventors: Bongcheol KIM, Dong Sik KIM, Jae-Keun LEE, Juwon SHIM
  • ADENO-ASSOCIATED VIRUS (AAV) DELIVERY OF ANTI-FAM19A5 ANTIBODIES
    Publication number: 20210388382
    Abstract: The present disclosure provides adeno-associated vims (AAV) vectors and uses thereof. In certain embodiments, the AAV vectors comprise a nucleic acid that encodes an antagonist against a family with sequence similarity 19, member A5 (FAM19A5) protein, e.g., anti-FAM19A5 antibody, e.g., anti-FAM19A5 scFv.
    Type: Application
    Filed: May 8, 2019
    Publication date: December 16, 2021
    Applicants: Neuracle Science Co., Ltd., Neuracle Genetics
    Inventors: Jong-Mook KIM, Dong Sik KIM, Juwon SHIM, Soon-gu KWON
  • Methods of treatment using anti-c-met antibodies
    Patent number: 10927177
    Abstract: The present disclosure provides a pharmaceutical composition for preventing or treating a variety of diseases through c-Met activation in cells induced by the anti-c-Met antibody described herein which functions as a c-Met agonist. The current invention concerns a method for preventing or treating various diseases through c-Met activation by the anti-c-Met antibody described herein.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: February 23, 2021
    Assignee: Helixmith Co., Ltd
    Inventors: Seung Shin Yu, Jae-Gyun Jeong, Dongsik Kim, Juwon Shim
  • USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS
    Publication number: 20200223914
    Abstract: The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to promote a blood vessel normalization and treat a disease (e.g., cancer) in a subject in need thereof, e.g., by promoting a blood vessel normalization.
    Type: Application
    Filed: June 27, 2018
    Publication date: July 16, 2020
    Applicant: Neuracle Science Co., Ltd.
    Inventors: Bongcheol KIM, Eun Bee CHO, Dong Sik KIM, Jae-Keun LEE, Soon-gu KWON, Jae Young SEONG, Juwon SHIM, Tae Woo KIM, Shin-hyuk KANG
  • ANTI-C-MET ANTIBODIES AND USES THEREOF
    Publication number: 20190315872
    Abstract: The present disclosure provides a pharmaceutical composition for preventing or treating a variety of diseases through c-Met activation in cells induced by the anti-c-Met antibody described herein which functions as a c-Met agonist. The current invention concerns a method for preventing or treating various diseases through c-Met activation by the anti-c-Met antibody described herein.
    Type: Application
    Filed: February 6, 2017
    Publication date: October 17, 2019
    Inventors: Seung Shin YU, Jae-Gyun JEONG, Dongsik KIM, Juwon SHIM